48 related articles for article (PubMed ID: 25694062)
1. CEA-targeted nanoparticles allow specific in vivo fluorescent imaging of colorectal cancer models.
Tiernan JP; Ingram N; Marston G; Perry SL; Rushworth JV; Coletta PL; Millner PA; Jayne DG; Hughes TA
Nanomedicine (Lond); 2015; 10(8):1223-31. PubMed ID: 25694062
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the tumor-targeting specific imaging and killing effect of a CEA-targeting nanoparticle in colorectal cancer.
Feng Q; Wang SA; Ning B; Xie J; Ding J; Liu S; Ai S; Li F; Wang X; Guan W
Biochem Biophys Res Commun; 2024 Jul; 719():150084. PubMed ID: 38733742
[TBL] [Abstract][Full Text] [Related]
3. Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
Hiroshima Y; Lwin TM; Murakami T; Mawy AA; Kuniya T; Chishima T; Endo I; Clary BM; Hoffman RM; Bouvet M
J Surg Oncol; 2016 Dec; 114(8):951-958. PubMed ID: 27696448
[TBL] [Abstract][Full Text] [Related]
4. Optimizing the performance of silica nanoparticles functionalized with a near-infrared fluorescent dye for bioimaging applications.
Ehrhorn EG; Lovell P; Svechkarev D; Romanova S; Mohs AM
Nanotechnology; 2024 May; 35(30):. PubMed ID: 38631329
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent multiblock π-conjugated polymer nanoparticles for in vivo tumor targeting.
Ahmed E; Morton SW; Hammond PT; Swager TM
Adv Mater; 2013 Aug; 25(32):4504-10. PubMed ID: 23794490
[TBL] [Abstract][Full Text] [Related]
6. Luminescent silica nanoparticles for cancer diagnosis.
Arap W; Pasqualini R; Montalti M; Petrizza L; Prodi L; Rampazzo E; Zaccheroni N; Marchiò S
Curr Med Chem; 2013; 20(17):2195-211. PubMed ID: 23458621
[TBL] [Abstract][Full Text] [Related]
7. Targeted Biodegradable Near-Infrared Fluorescent Nanoparticles for Colorectal Cancer Imaging.
Chung SJ; Hadrick K; Nafiujjaman M; Apu EH; Hill ML; Nurunnabi M; Contag CH; Kim T
ACS Appl Bio Mater; 2024 Apr; ():. PubMed ID: 38574012
[TBL] [Abstract][Full Text] [Related]
8. Targeted Enzyme Activity Imaging with Quantitative Phase Microscopy.
Tanwar S; Wu L; Zahn N; Raj P; Ghaemi B; Chatterjee A; Bulte JWM; Barman I
Nano Lett; 2023 May; 23(10):4602-4608. PubMed ID: 37154678
[TBL] [Abstract][Full Text] [Related]
9. Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle.
Khaled YS; Khot MI; Aiyappa-Maudsley R; Maisey T; Pramanik A; Tiernan J; Lintern N; Al-Enezi E; Shamsuddin SH; Tomlinson D; Coletta L; Millner PA; Hughes TA; Jayne DG
Nanoscale; 2024 Apr; 16(14):7185-7199. PubMed ID: 38506227
[TBL] [Abstract][Full Text] [Related]
10. Application of Nanoparticles in the Diagnosis of Gastrointestinal Diseases: A Complete Future Perspective.
Yue NN; Xu HM; Xu J; Zhu MZ; Zhang Y; Tian CM; Nie YQ; Yao J; Liang YJ; Li DF; Wang LS
Int J Nanomedicine; 2023; 18():4143-4170. PubMed ID: 37525691
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic-Acid-Tagged Cubosomes Deliver Cytotoxics Specifically to CD44-Positive Cancer Cells.
Pramanik A; Xu Z; Ingram N; Coletta PL; Millner PA; Tyler AII; Hughes TA
Mol Pharm; 2022 Dec; 19(12):4601-4611. PubMed ID: 35938983
[TBL] [Abstract][Full Text] [Related]
12. Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using
Pramanik A; Xu Z; Shamsuddin SH; Khaled YS; Ingram N; Maisey T; Tomlinson D; Coletta PL; Jayne D; Hughes TA; Tyler AII; Millner PA
ACS Appl Mater Interfaces; 2022 Mar; 14(9):11078-11091. PubMed ID: 35196008
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible.
Lwin TM; Turner MA; Amirfakhri S; Nishino H; Hoffman RM; Bouvet M
Cells; 2022 Jan; 11(2):. PubMed ID: 35053365
[TBL] [Abstract][Full Text] [Related]
14.
Wang S; Wang S; Wang W; Dai Y; Qiu Z; Ke W; Geng M; Li J; Li K; Ma Q; Li F
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0079521. PubMed ID: 34460300
[TBL] [Abstract][Full Text] [Related]
15. Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications.
Azizi M; Dianat-Moghadam H; Salehi R; Farshbaf M; Iyengar D; Sau S; Iyer AK; Valizadeh H; Mehrmohammadi M; Hamblin MR
Adv Funct Mater; 2020 May; 30(19):. PubMed ID: 34093104
[TBL] [Abstract][Full Text] [Related]
16. Selection and characterisation of Affimers specific for CEA recognition.
Shamsuddin SH; Jayne DG; Tomlinson DC; McPherson MJ; Millner PA
Sci Rep; 2021 Jan; 11(1):744. PubMed ID: 33436840
[TBL] [Abstract][Full Text] [Related]
17. GPI-AP: Unraveling a New Class of Malignancy Mediators and Potential Immunotherapy Targets.
Hussein NH; Amin NS; El Tayebi HM
Front Oncol; 2020; 10():537311. PubMed ID: 33344222
[TBL] [Abstract][Full Text] [Related]
18. Targeting and imaging colorectal cancer by activatable cell-penetrating peptides.
Zeng Z; Chen J; Luo S; Dong J; Hu H; Yang Z; Feng X; Liu Y; Liu B; Pan G; Zhou FH; Wang L; Kang L
Am J Transl Res; 2020; 12(5):1754-1766. PubMed ID: 32509174
[TBL] [Abstract][Full Text] [Related]
19. Nanovectors Design for Theranostic Applications in Colorectal Cancer.
Rampado R; Crotti S; Caliceti P; Pucciarelli S; Agostini M
J Oncol; 2019; 2019():2740923. PubMed ID: 31662751
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
